Rigalleau Vincent, Lasseur Catherine, Raffaitin Christelle, Beauvieux Marie-Christine, Barthe Nicole, Chauveau Philippe, Combe Christian, Gin Henri
Department of Nutrition-Diabétologie, Hôpital Haut-Lévêque, Avenue de Magellan, 33600 Pessac, France.
Diabetes Care. 2007 Aug;30(8):2034-9. doi: 10.2337/dc07-0140. Epub 2007 May 7.
About 20% of diabetic patients with chronic kidney disease (CKD) detected from the new American Diabetes Association recommendations (albumin excretion rate >30 mg/24 h or estimated glomerular filtration rate [GFR] <60 ml/min per 1.73 m2) may be normoalbuminuric. Do the characteristics and outcome differ for subjects with and without albuminuria?
A total of 89 patients with diabetes and a modification of diet in renal disease (MDRD) estimated GFR (e-GFR) <60 ml/min per 1.73 m2 underwent a 51Cr-EDTA B-isotopic GFR determination and were followed up for 38 +/- 11 months.
The mean MDRD e-GFR (41.3 +/- 13.1 ml/min per 1.73 m2) did not significantly differ from the i-GFR (45.6 +/- 29.7). Of the subjects, 15 (17%) were normoalbuminuric. Their i-GFR did not differ from the albuminuric rate and from their MDRD e-GFR, although their serum creatinine was lower (122 +/- 27 vs. 160 +/- 71 micromol/l, P < 0.05): 71% would not have been detected by measuring serum creatinine (sCr) alone. They were less affected by diabetic retinopathy, and their HDL cholesterol and hemoglobin were higher (P < 0.05 vs. albuminuric). None of the CKD normoalbuminuric subjects started dialysis (microalbuminuric: 2/36, macroalbuminuric: 10/38) or died (microalbuminuric: 3/36, macroalbuminuric: 7/38) during the follow-up period (log-rank test: P < 0.005 for death or dialysis), and their albumin excretion rate and sCr values were stable after 38 months, whereas the AER increased in the microalbuminuric patients (P < 0.05), and the sCr increased in the macroalbuminuric patients (P < 0.01).
Although their sCr is usually normal, most of the normoalbuminuric diabetic subjects with CKD according to an MDRD e-GFR below 60 ml/min per 1.73 m2 do really have a GFR below 60 ml/min per 1.73 m2. However, as expected, because of normoalbuminuria and other favorable characteristics, their risk for CKD progression or death is lower.
根据美国糖尿病协会新指南检测出的慢性肾脏病(CKD)糖尿病患者中,约20%可能为正常白蛋白尿。有蛋白尿和无蛋白尿的患者在特征和预后方面是否存在差异?
共有89例糖尿病患者,其肾脏病饮食改良(MDRD)估算肾小球滤过率(e-GFR)<60 ml/(min·1.73 m²),接受了51Cr-EDTA B同位素GFR测定,并随访38±11个月。
MDRD平均e-GFR(41.3±13.1 ml/(min·1.73 m²))与同位素测定的GFR(i-GFR,45.6±29.7)无显著差异。其中15例(17%)为正常白蛋白尿。他们的i-GFR与白蛋白尿患者以及MDRD e-GFR无差异,尽管其血清肌酐较低(122±27 vs. 160±71 μmol/L,P<0.05):仅通过检测血清肌酐(sCr),71%的患者无法被检测出来。他们受糖尿病视网膜病变的影响较小,高密度脂蛋白胆固醇和血红蛋白水平较高(与白蛋白尿患者相比,P<0.05)。在随访期间,CKD正常白蛋白尿患者均未开始透析(微量白蛋白尿:2/36,大量白蛋白尿:10/38)或死亡(微量白蛋白尿:3/36,大量白蛋白尿:7/38)(对数秩检验:死亡或透析P<0.005),且38个月后其白蛋白排泄率和sCr值稳定,而微量白蛋白尿患者的AER升高(P<0.05),大量白蛋白尿患者的sCr升高(P<0.01)。
尽管大多数根据MDRD e-GFR低于60 ml/(min·1.73 m²)诊断为CKD的正常白蛋白尿糖尿病患者的sCr通常正常,但他们的GFR确实低于60 ml/(min·1.73 m²)。然而,正如预期的那样,由于正常白蛋白尿和其他有利特征,他们CKD进展或死亡的风险较低。